Anti-inflammatory therapy in chronic obstructive pulmonary disease: present and future
Today chronic obstructive pulmonary disease is a major economic and social challenge and the only disease causing an ever-increasing number of fatalities [4, 5]. According to a number of recently completed studies, the prevalence of chronic lung diseases in people aged over 40 years is 10.1 per cent...
Main Author: | S. N. Avdeev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2013-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/934 |
Similar Items
-
Chronic obstructive pulmonary disease: in search of effective ways of control
by: A. A. Vizel, et al.
Published: (2013-12-01) -
Микробиом мокроты у пожилых пациентов с различными клиническими фенотипами хронической обструктивной болезни легких
by: Наталья Яковлевна Дзеранова, et al.
Published: (2022-01-01) -
COVID-19 and chronic obstructive pulmonary disease: what is known about the unknown
by: E. S. Ovsyannikov, et al.
Published: (2021-03-01) -
CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DEFINITION, EPIDEMIOLOGY, PATHOPHYSIOLOGY, CLINICAL PICTURE AND TREATMENT (GOLD 2013)
by: M. T. Vatutin, et al.
Published: (2015-12-01) -
Eosinophils as a non-invasive marker to assess inflammatory activities in those suffering from chronic obstructive pulmonary disease
by: M. A. Kаrnаushkinа, et al.
Published: (2018-11-01)